Hofseth BioCare ASA
Hofseth BioCare ASA (HOFBF) Revenue
Annual & quarterly revenue history · segment & region breakdown
HOFBF · revenue · updated Jun 9, 2026
Core revenue metrics
Trailing 12 monthsHofseth BioCare ASA trailing twelve-month (TTM) revenue is $0.26B, a decrease of 1.22% year-over-year from $0.25B in FY2025.
Revenue trend
2025 – 2010 · AnnualRevenue history
| Fiscal year end | Revenue | Change | Growth |
|---|---|---|---|
| 2025-12-31 | $0.25B | -$0.00B | -1.22% |
| 2024-12-31 | $0.26B | +$0.06B | +32.09% |
| 2023-12-31 | $0.19B | +$0.07B | +61.79% |
| 2022-12-31 | $0.12B | +$0.03B | +37.47% |
| 2021-12-31 | $0.09B | +$0.02B | +26.52% |
| 2020-12-31 | $0.07B | +$0.00B | +2.17% |
| 2019-12-31 | $0.07B | +$0.01B | +11.59% |
| 2018-12-31 | $0.06B | -$0.06B | -48.73% |
| 2017-12-31 | $0.12B | +$0.10B | +486.40% |
| 2016-12-31 | $0.02B | -$0.03B | -63.36% |
About Revenue & Reporting
Revenue (also called sales, net sales, or turnover) is the total income Hofseth BioCare ASA receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.
Hofseth BioCare ASA reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in NOK.
Data sourced from Hofseth BioCare ASA's 10-K and 10-Q SEC filings via Financial Modeling Prep.
Frequently asked questions
HOFBF revenue · 4 questionsHOFBF's trailing twelve-month (TTM) revenue is $0.26B. That is a decrease of 1.22% year-over-year from $0.25B in FY2025.
▸ Source: FMP · Hofseth BioCare ASA SEC filings · GAAP · Hofseth BioCare ASA SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026